NICE on u/s-guided foam sclerotherapy:
This article was originally published in Clinica
Executive Summary
The UK National Institute for Health and Clinical Excellence (NICE) has deemed ultrasound-guided foam sclerotherapy to be effective in treating varicose veins in the short term. In an update of the interventional procedures (IP) guidance it issued on the technique in June 2006, NICE notes "transient side effects in a small proportion of patients", thereby requiring special arrangements for consent and audit/research. The guidance has been endorsed by NHS Quality Improvement Scotland, making it valid for the whole of the UK. However, IP appraisals do not assess clinical demand for the procedure - nor have they any legal weight - so provide no indication of their impact on the use of the technologies involved. The "special arrangements" attached to NICE's decisions on interventional procedures are the subject of an open consultation.
You may also be interested in...
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.